https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
As regards DG treatment, a central role is played by dietary modification and glucose control and the first-line pharmacological therapy is represented by the use of prokinetics. A minority of patients with DG refractory to medical treatment may require more invasive therapeutic approaches, including supplemental nutrition, gastric electric stimulation, pyloromyotomy and gastrectomy.The melanocortin system is involved in the control of adiposity through modulation of food intake and energy expenditure. The single nucle
Me gusta
Comentario
Compartir
